InvestorsHub Logo

Brodster

06/23/17 10:41 AM

#65867 RE: Ronin_Trader #65800

This is huge imo!

The recent partnership with Eltron R&D, including the exclusive rights to the ImPAAct© Peracetic Acid Technology for the Cannabis Markets in Colorado, Canada and Israel, is providing the company with a new high-margin product and service. Peracetic Acid is growing in popularity as a disinfectant and the ImPAAct© Technology is a patented method of producing the product that cuts costs and has added features. Cannabis Clean and Eltron will partner on expanding the scope of this project to include the remaining states in the US.

JPS02

06/25/17 2:51 PM

#65984 RE: Ronin_Trader #65800

Blue Diamond Consulting LLC – has planning and development projects, as well as business development and product development projects in traditional industries. (Jonathan Alper, manager of Blue Diamond Consulting spoke about some of the planning projects, including Victory Christian Church) The project consists of a 100-acre parcel in Pendleton NY, 10 miles North of Buffalo NY.

The original feasibility study was completed in May and billing of $8K per month commenced on June 1st, with Jonathan acting as Project Manager for the Church. As the project proceeds with Residential Development, Commercial Development, Solar Energy Production and Wetland Park Development, Blue Diamond will act as Master Planners, Construction Managers, and Developer Coordinators with estimated fees reaching $25K per month by January 1, 2018, with the project lasting over 2 years. Blue Diamond continues to provide land planning services to religious and other organization in the Chicagoland Area.

Extract source - 6/20/17 Shareholder Conference Call Recap:

https://www.otcmarkets.com/ajax/showNewsReleaseDocumentById.pdf?id=26099

- It looks there are some fair potential revenues from this project alone that can pay a few bills this year and next year:

Estimated minimum billings for this project - 2017 = 7 x $8K/month = $56K

Estimated billings for this project - 2018 = 12 x $25K/month = $300K

I like this part of the CC because it is good follow through on 9:03 in the Interview: CEO Joshua Alper of Blue Diamond Ventures, Inc. published on June 1, 2017 where the CEO indicates that his objective is to build revenues:



Go BLDV!

JPS02

06/25/17 10:26 PM

#65998 RE: Ronin_Trader #65800

Question 8 is key: In mid-May, Jonathan Alper conducted a second round of meetings with a technology accelerator and multiple medical device manufacturers and IP holders, this round was focused on logistics and export/import standards.

I believe the key value prospects in this CC response are based on the following four important items presented in the response:

1. Technology accelerator

2. Multiple medical device manufacturers

3. IP holders

4. Logistics and export/import standards

Any single or combination of items 1 to 3 plus item 4 can bring significant value to a company in general.

We know that something is going on with BLDV, Eltron Research, Israel and MJ that is timely based on the industry dynamics, Isreal's leadership in the industry and the prior updates we have received from BLDV:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132391537

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132085237

These updates and the CC response are supported by the CEO's statement at 9:45 in the Interview: CEO Joshua Alper of Blue Diamond Ventures, Inc. published on June 1, 2017 where the CEO describes the amount of efforts they have expended to develop the Israel connection to build a couple of partnerships that will drive significant revenue by the end of the year.



Time will tell how significant the Israeli partnerships will be to BLDV.

Go BLDV!

Ronin_Trader

06/28/17 11:52 AM

#66227 RE: Ronin_Trader #65800

NEWS 6/28 - Blue Diamond Ventures Inc. announces first Israeli Cannabis Project

Cannabis-Clean will develop Next Generation of High-Tech Cleaning Standards in Israel.


June 28, 2017 Blue Diamond Ventures Inc. (OTC PK: BLDV) – Denver Colorado:

Blue Diamond Ventures Inc. (BLDV) and their wholly owned subsidiary Cannabis-Clean of Denver, will work with existing Israeli Cannabis Farms, Government Regulators, and third-party Certification Agencies to develop Sanitation and Anti-Bacterial protocols that will comply with the new GAP and GMP standards being developed in Israel.

“As Israel moves Cannabis closer to the Pharmaceutical Stage, the development of specific standards in cleaning and sanitation for Medical Cannabis becomes even more important.” said Josh Alper, CEO of Blue Diamond. “Medical Marijuana is a loose description in today’s market, we are preparing for a coming environment that will require a real High-Tech approach to meeting regulations and standards.

Cannabis Clean has been working on a Nano-Surface-Technology approach for over 3 years, identifying the Standard Operating Procedures (SOP) for the Cannabis Industry. A Strategic Partnership with Eltron R&D, a Material Science Laboratory, announced last month, has taken this work to the next level.

Patented Peracetic Acid or PAA technology, marketed under the name ImPAActTM will be central to facilities reaching compliance with new Medical cannabis standards that are being implemented not only in the USA, but also in Europe, Canada and Mexico.

“Mycotoxin testing is coming, and will be a real gamer changer, this is where the PAA will really make an impact on the Industry” said Steve McMorrow, President of Cannabis Clean, “PAA is one of the few ways to remove Mycotoxins from the environment in a Cannabis facility that does not leave any residue that would turn up in testing. The SOP’s developed in Israel will become the standard of the industry and will define our process moving forward”

Jonathan Alper of Blue Diamond Consulting LLC will head up the effort in Israel, Jonathan is fluent in Hebrew and has worked in the past with the Israeli Government on Hospital and Prison standards. “We are currently interviewing technical translators to ensure that we can both benefit from the new standards being adopted in Israel, and contribute with our experience” said Mr. Alper.

About BLDV:

Blue Diamond Ventures, Inc. seeks to partner with individuals and companies that share a common synergy, mission and vision to enable products/services that are produced, delivered and consumed utilizing fewer natural resources, providing a sustainable alternative to traditional products on the market today. As a diversified customer, centric Management / Holding Company; Blue Diamond Ventures, Inc. seeks opportunities in various markets and is driven by critical thinking and the scientific method.

Safe Harbor:
This press release contains forward-looking statements. Such forward-looking statements are subject to several risks, assumptions, and uncertainties that could cause the Company's actual results to differ materially from those projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly revise any forward-looking statements.

Contact:
Blue Diamond Ventures Inc. 535 N. Michigan Ave. Suite
Joshua B. Alper CEO?(844) 637-6377 info@bldvinc.com www.bldvinc.com

http://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--announces-first-Israeli-Cannabis-Project?id=163387&b=y

JPS02

07/03/17 9:04 PM

#66662 RE: Ronin_Trader #65800

Question 8 is key: In mid-May, Jonathan Alper conducted a second round of meetings with a technology accelerator and multiple medical device manufacturers and IP holders, this round was focused on logistics and export/import standards.

I believe the key value prospects in this CC response are based on the following four important items presented in the response:

1. Technology accelerator

2. Multiple medical device manufacturers

3. IP holders

4. Logistics and export/import standards

Any single or combination of items 1 to 3 plus item 4 can bring significant value to a company in general.

We know that something is going on with BLDV, Eltron Research, Israel and MJ that is timely based on the industry dynamics, Isreal's leadership in the industry and the prior updates we have received from BLDV:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132391537

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132085237

These updates and the CC response are supported by the CEO's statement at 9:45 in the Interview: CEO Joshua Alper of Blue Diamond Ventures, Inc. published on June 1, 2017 where the CEO describes the amount of efforts they have expended to develop the Israel connection to build a couple of partnerships that will drive significant revenue by the end of the year.



Time will tell how significant the Israeli partnerships will be to BLDV.

Go BLDV!

JPS02

07/10/17 7:32 PM

#66999 RE: Ronin_Trader #65800

Question 8 is key: In mid-May, Jonathan Alper conducted a second round of meetings with a technology accelerator and multiple medical device manufacturers and IP holders, this round was focused on logistics and export/import standards.

I believe the key value prospects in this CC response are based on the following four important items presented in the response:

1. Technology accelerator

2. Multiple medical device manufacturers

3. IP holders

4. Logistics and export/import standards

Any single or combination of items 1 to 3 plus item 4 can bring significant value to a company in general.

We know that something is going on with BLDV, Eltron Research, Israel and MJ that is timely based on the industry dynamics, Isreal's leadership in the industry and the prior updates we have received from BLDV:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132391537

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132085237

These updates and the CC response are supported by the CEO's statement at 9:45 in the Interview: CEO Joshua Alper of Blue Diamond Ventures, Inc. published on June 1, 2017 where the CEO describes the amount of efforts they have expended to develop the Israel connection to build a couple of partnerships that will drive significant revenue by the end of the year.



Time will tell how significant the Israeli partnerships will be to BLDV.

Go BLDV!